| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |